Physician profile
Eric C Kim
NPI 1992872105
$1,130.58
in general payments reported to CMS, 2019-2025
10 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.47 · 2021: $135 · 2022: $45.96 · 2023: $200 · 2024: $503 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $445.47 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $230.81 | 2024 | Intellis Adaptivestim |
| Ivantis, INC | $135.39 | 2021 | |
| Avanos Medical | $88.73 | 2022-2023 | Generator |
| Saluda Medical Americas, INC. | $74.60 | 2023-2025 | Evoke Scs, Evoke |
| Globus Medical, INC. | $53.05 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $35.01 | 2023-2024 | Iovera |
| Spr Therapeutics, INC | $27.60 | 2023 | Sprint Pns System |
| Abbott Laboratories | $21.45 | 2023 | Proclaim |
| Si-Bone, INC. | $18.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.